Aster DM Healthcare Q4 net profit up 7.1 percent to Rs 219.84 crore

Published On 2019-05-31 04:00 GMT   |   Update On 2019-05-31 04:00 GMT

"We are very happy to report strong growth at both the top line and EBITDA (Earnings before interest, tax, depreciation and amortisation) level. All hospitals in the GCC and India are performing well and new hospitals in India are also doing better than expected," Aster DM Healthcare Chairman Azad Moopen said.


New Delhi: Healthcare services provider Aster DM Healthcare on May 27 reported a 7.12 per cent increase in consolidated net profit at Rs 219.84 crore for the fourth quarter ended March 2019.


The company had posted a net profit of Rs 205.22 crore in January-March 2018, Aster DM Healthcare said in a filing to the BSE.


Total income during the March quarter stood at Rs 2,208.50 crore, up 23.14 per cent, from Rs 1,793.41 crore in the year-ago quarter.


Read Also: Aster DM Healthcare to infuse Rs 750 crore to add 1500 beds in four new hospitals


"We are very happy to report strong growth at both the top line and EBITDA (Earnings before interest, tax, depreciation and amortisation) level. All hospitals in the GCC and India are performing well and new hospitals in India are also doing better than expected," Aster DM Healthcare Chairman Azad Moopen said.




Total expenses during the latest quarter rose 22.20 per cent to Rs 1,983.91 crore against Rs 1,623.46 crore in the year-ago period.



For the financial year 2018-19, net profit increased 30.39 per cent to Rs 367.31 crore from Rs 281.69 crore in 2017-18.

Total income for the last fiscal stood at Rs 7,997.33 crore, up 18.18 per cent as compared with Rs 6,766.60 crore in the previous year.

Read Also: Moopen backed Aster DM to infuse about Rs 1000 crore in Indian Hospitals by 2021: Report


Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News